fda bpc-157 ineligible for compounding 503a 503b Regulatory Alert: The Legal Status of in and Clinical Practice – Holt Law BPC-157 Legal Status, FDA 503A
Description
Two separate human clinical trials have investigated this compound: Ulcerative Colitis Trial Clinical investigation of this compound in patients with ulcerative colitis examined the compounds GI-protective properties properties that are consistent with its gastric origin and documented activity on intestinal permeability barriers in animal models
US-based compounding pharmacies working with veterinarians are the safest source
Before taking Wegovy pills, tell your doctor if you: Some medications may interact with the Wegovy pill and make it unsuitable for you
L.DumitrascuD
Using Samsung Health to track progress
For more on how this combination works, see Meto's deep dive on the CJC-1295 and Ipamorelin stack
